COPD Awareness Month

Lung Association Launches 'COPD for Life' to Enhance Lives of People Living with Long-Term COPD

Retrieved on: 
Wednesday, November 8, 2023

CHICAGO, Nov. 8, 2023 /PRNewswire/ -- Chronic obstructive pulmonary disease (COPD) is a life-long chronic lung disease that makes it difficult to breathe. During COPD Awareness Month in November, the American Lung Association launched the new "COPD for Life" campaign, with support from Sanofi and Regeneron, to help people who have been living with the disease for ten or more years live better, more active and enjoyable lives.

Key Points: 
  • COPD, which includes chronic bronchitis and emphysema, is a long-term lung disease that makes it hard to breathe.
  • Women, people of lower socioeconomic status, and those living in rural areas have a greater likelihood of developing COPD and poor disease-related outcomes.
  • As a part of this campaign, the Lung Association conducted a comprehensive review of literature to examine how to best help people living with COPD.
  • The Lung Association will provide resources that are more accessible to those carrying the highest burden of COPD.

Physician identifies types of fainting and when to seek medical attention

Retrieved on: 
Tuesday, September 12, 2023

LOMA LINDA, Calif., Sept. 12, 2023 /PRNewswire-PRWeb/ -- Roughly three in four Americans have fainted or know someone who has fainted, according to a national survey by Syncope Trust and Reflex Anoxic Seizures. Syncope, the medical term for fainting or passing out, is a temporary loss of consciousness and could indicate an underlying cardiac condition.

Key Points: 
  • Syncope, the medical term for fainting or passing out, is a temporary loss of consciousness and could indicate an underlying cardiac condition.
  • In anticipation of October's Sudden Cardiac Arrest (SCA) Awareness Month, Contactor describes types of fainting, what fainting may signal about your heart health, and why you should seek medical attention directly after experiencing an episode to find out.
  • The most common type of syncope is vasovagal: fainting from a sudden drop in heart rate and blood pressure.
  • Contractor warns to seek medical attention after any fainting episode, even if you suspect the cause was fatigue, heat, dehydration, or an emotional response.

Telehealth Market size is set to grow by USD 170.82 billion from 2022 to 2027, The growing incidences and prevalence of chronic diseases to boost the market growth - Technavio

Retrieved on: 
Thursday, June 15, 2023

The growing incidences and prevalence of chronic diseases such as cardiovascular diseases (CVDs), cancer, Alzheimer's disease, asthma, chronic obstructive pulmonary diseases (COPDs), and diabetes predominately drive the growth of the telehealth market.

Key Points: 
  • The growing incidences and prevalence of chronic diseases such as cardiovascular diseases (CVDs), cancer, Alzheimer's disease, asthma, chronic obstructive pulmonary diseases (COPDs), and diabetes predominately drive the growth of the telehealth market.
  • The market share growth by the services segment will be significant for the growth of the global telehealth market during the forecast period.
  • The report provides actionable insights and estimates the contribution of all regions to the growth of the global telehealth market.
  • The growing prevalence of mental health disorders is the key factor driving the growth of the global mental health application market.

November is PH Awareness Month. Learn About Pulmonary Hypertension Day by Day with Interactive Calendar

Retrieved on: 
Tuesday, October 11, 2022

WASHINGTON, October 11, 2022 /PRNewswire-PRWeb/ -- Each November, the Pulmonary Hypertension Association (PHA) launches a national campaign to raise awareness about pulmonary hypertension (PH). This progressive rare disease is defined by high blood pressure in the lungs and can cause right-heart failure and even death.

Key Points: 
  • The Pulmonary Hypertension Association's "PHacing the Future Day by Day" campaign strives to educate people about pulmonary hypertension through an interactive online calendar.
  • WASHINGTON, October 11, 2022 /PRNewswire-PRWeb/ -- Each November, the Pulmonary Hypertension Association (PHA) launches a national campaign to raise awareness about pulmonary hypertension (PH).
  • Throughout November, PHA will educate people about risk factors and symptoms of PH through its award-winning interactive, online PH Awareness Month calendar.
  • The calendar reveals a new fact or tool daily, along with downloadable resources to raise PH awareness.

Boehringer Ingelheim Canada supports PF Awareness Month with Life with PF campaign

Retrieved on: 
Monday, September 20, 2021

BURLINGTON, ON, Sept. 20, 2021 /CNW/ - September is Pulmonary Fibrosis (PF) Awareness Month, a time to raise awareness of PF and support those who have been diagnosed with this rare lung disease.

Key Points: 
  • BURLINGTON, ON, Sept. 20, 2021 /CNW/ - September is Pulmonary Fibrosis (PF) Awareness Month, a time to raise awareness of PF and support those who have been diagnosed with this rare lung disease.
  • This year, to help patients understand the progression of this irreversible disease, and to empower them to get the care they need, Boehringer Ingelheim (Canada) Ltd. has created the Life with PF campaign.
  • "PF is a progressive disease that becomes worse over time," says Sharon Lee, Executive Director of the Canadian Pulmonary Fibrosis Foundation.
  • ABOUT BOEHRINGER INGELHEIM CANADA LTD.
    Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals.

Emphysema Foundation of America and Olympus Collaborate on Virtual Lung Health Education Series

Retrieved on: 
Thursday, July 15, 2021

LOS ANGELES and CENTER VALLEY, Pa., July 15, 2021 /PRNewswire/ --The Emphysema Foundation of America (EFA) and medical device corporation Olympus Corporation of the Americas will partner in providing a virtual lung health education series on chronic obstructive pulmonary disease (COPD).

Key Points: 
  • LOS ANGELES and CENTER VALLEY, Pa., July 15, 2021 /PRNewswire/ --The Emphysema Foundation of America (EFA) and medical device corporation Olympus Corporation of the Americas will partner in providing a virtual lung health education series on chronic obstructive pulmonary disease (COPD).
  • The series will feature five free virtual workshops to educate COPD patients, caregivers of COPD patients, and health care providers.
  • "The Emphysema Foundation of America is proud to serve those individuals and families suffering with emphysema and COPD," said Carrel.
  • Olympus Corporation of the Americas is headquartered in Center Valley, Pennsylvania, USA, with 5,500 employees throughout North and South America.

Pri-Med Partners with NHLBI's Learn More Breathe Better to Provide Primary Care Clinicians with New Asthma Guidelines

Retrieved on: 
Monday, December 21, 2020

Coordinated by Learn More Breathe Better, the Network is comprised of organizations and programs across the country, including state and federal agencies, nonprofits, civic groups, professional associations, health systems, and research organizations.

Key Points: 
  • Coordinated by Learn More Breathe Better, the Network is comprised of organizations and programs across the country, including state and federal agencies, nonprofits, civic groups, professional associations, health systems, and research organizations.
  • The Breathe Better Network helps drive outreach efforts to increase awareness of lung health, including COPD and asthma as serious, yet manageable and treatable conditions.
  • "We'll continue to develop timely, relevant CME/CE for primary care clinicians that focuses on important topics like asthma and COPD during upcoming educational initiatives, including our PrimaryCareNOW virtual conference series."
  • To learn more about the 2020 Focused Updates to the Asthma Management Guidelines and find clinician and patient education materials, visit http://www.nhlbi.nih.gov/asthmaguidelines .

Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease

Retrieved on: 
Tuesday, August 11, 2020

Launched in 1997 in collaboration with the National Heart, Lung, and Blood Institute of U.S. National Institutes of Health and the World Health Organization , GOLD is a global initiative to raise awareness of chronic obstructive pulmonary disease ("COPD") and to improve prevention and treatment of this lung disease for patients around the world.

Key Points: 
  • Launched in 1997 in collaboration with the National Heart, Lung, and Blood Institute of U.S. National Institutes of Health and the World Health Organization , GOLD is a global initiative to raise awareness of chronic obstructive pulmonary disease ("COPD") and to improve prevention and treatment of this lung disease for patients around the world.
  • The Project decomposes the guidelines covered in the latest GOLD Report (2020 Edition) and converts them into scene-based, live interactive programs/courses.
  • The Project is a result of the close collaboration between Zhongchao and CAHPE along with the deep involvement of many subject experts.
  • The Company undertakes no obligation to publicly revise these forwardlooking statements to reflect events or circumstances that arise after the date hereof.

Deborah Heart and Lung Center Introduces Remote Patient Monitoring for COPD Patients

Retrieved on: 
Tuesday, May 26, 2020

BROWNS MILLS, N.J., May 26, 2020 /PRNewswire-PRWeb/ --Deborah Heart and Lung Center, New Jersey's only specialty heart, lung, and vascular hospital, and an Alliance member of the Cleveland Clinic Heart, Vascular & Thoracic Institute, has announced the introduction of remote patient monitoring for patients diagnosed with chronic obstructive pulmonary disease (COPD).

Key Points: 
  • BROWNS MILLS, N.J., May 26, 2020 /PRNewswire-PRWeb/ --Deborah Heart and Lung Center, New Jersey's only specialty heart, lung, and vascular hospital, and an Alliance member of the Cleveland Clinic Heart, Vascular & Thoracic Institute, has announced the introduction of remote patient monitoring for patients diagnosed with chronic obstructive pulmonary disease (COPD).
  • Patients diagnosed with COPD require physician monitoring to prevent the disease from progressing.
  • With the expansion of telemedicine and remote monitoring services prompted by the Coronavirus epidemic, Deborah has instituted a new remote patient monitoring services platform.
  • Called HGE Care the remote monitoring platform is designed for COPD patients who have been discharged from the hospital and are recuperating at home.

Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028

Retrieved on: 
Friday, January 24, 2020

The most commonly used severity criteria is the Global Initiative for Chronic Obstructive Lung Disease (GOLD) standard.

Key Points: 
  • The most commonly used severity criteria is the Global Initiative for Chronic Obstructive Lung Disease (GOLD) standard.
  • The report includes a 10-year epidemiological forecast for the total prevalent and diagnosed prevalent cases of COPD in the 7MM.
  • In the 7MM, epidemiologists forecast an increase in the total prevalent cases of COPD from 59,286,188 cases in 2018 to 67,185,113 cases in 2028 at an AGR of 1.33% during the forecast period.
  • - The Chronic Obstructive Pulmonary Disease (COPD) Epidemiology Report provides an overview of the risk factors and global trends of COPD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).